ADUS (Addus HomeCare) Research & Development: $0 Mil (TTM As of Mar. 2026)


ADUS Addus HomeCare Corp ADUS
92 GF Score
Price $97.78
GF Value $123.39
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Addus HomeCare Research & Development?

Addus HomeCare ADUS +1.75% 92 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates ADUS with a GF Score™ of 92/100 and a GF Value™ of $123.39 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Addus HomeCare's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Addus HomeCare  (NAS:ADUS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Addus HomeCare Research & Development Related Terms

Addus HomeCare Research & Development Historical Data

* Premium members only.

The historical data trend for Addus HomeCare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Addus HomeCare Research & Development Chart

Addus HomeCare Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Addus HomeCare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ADUS
92GF Score
Addus HomeCare Corp ADUS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Addus HomeCare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Addus HomeCare (ADUS) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Addus HomeCare and its competitors.
Is Addus HomeCare's Research & Development too high?
Addus HomeCare's current Research & Development is $0 Mil. Overall, Addus HomeCare has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Addus HomeCare's Research & Development compare to SGRY and SNDA?
Addus HomeCare's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Addus HomeCare and its competitors. Addus HomeCare's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Addus HomeCare stock overvalued right now?
Based on GuruFocus' analysis, Addus HomeCare (ADUS) is currently considered Modestly Undervalued. The stock's GF Value™ is $123.39, compared to a current price of $97.78 — trading 20.8% below its estimated fair value. The current Research & Development is $0 Mil. Addus HomeCare's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Addus HomeCare (ADUS), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Addus HomeCare (ADUS) Overvalued in 2026?

Based on GuruFocus' analysis, Addus HomeCare stock appears to be undervalued. The current stock price of $97.78 is trading 20.8% below its estimated GF Value™ of $123.39. GuruFocus considers Addus HomeCare to be Modestly Undervalued.

Key valuation signals for ADUS:

  • Research & Development: $0 Mil
  • GF Value™: $123.39 vs. price of $97.78 (20.8% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the ADUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Addus HomeCare Business Description

Other Exchanges A41:Germany
Address 6303 Cowboys Way, Suite 600, Frisco, TX, USA, 75034
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
92GF Score

Get the complete analysis for ADUS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$97.78
Price
$123.39
GF Value